Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) EV-to-EBIT : 1.45 (As of Jun. 11, 2024)

Aoxing Pharmaceutical Co EV-to-EBIT Chart

Aoxing Pharmaceutical Co Annual Data
	Trend	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16
EV-to-EBIT		Get a 7-Day Free Trial					-1.65	-2.31	-13.33	17.01	10.48

Aoxing Pharmaceutical Co Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
EV-to-EBIT	Get a 7-Day Free Trial															5.99	10.48	12.09	25.02	50.87

Competitive Comparison of Aoxing Pharmaceutical Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Aoxing Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aoxing Pharmaceutical Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aoxing Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's EV-to-EBIT falls into.

Aoxing Pharmaceutical Co EV-to-EBIT Calculation

Aoxing Pharmaceutical Co's EV-to-EBIT for today is calculated as:

Aoxing Pharmaceutical Co's current Enterprise Value is $1.43 Mil.
Aoxing Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxing Pharmaceutical Co  (OTCPK:AOXG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Aoxing Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2017 is calculated as:

Aoxing Pharmaceutical Co's Enterprise Value for the quarter that ended in Mar. 2017 was $50.11 Mil.
Aoxing Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxing Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description